Leyre Silva

Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.

J. Prieto, J. Lasarte, A. Zabaleta, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

B. Sangro, J. Quiroga, J. Herrero, 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10

P. Sarobe, Diana Llópiz, Leyre Silva, 2018, Front. Immunol..

Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy.

J. Berzofsky, D. Stroncek, J. Lasarte, 2020, Cancer letters.

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

Ibon Tamayo, S. Hervás-Stubbs, J. Lasarte, 2022, Frontiers in Immunology.

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination

Flor Navarro, S. Hervás-Stubbs, J. Lasarte, 2022, Frontiers in Immunology.

Neoantigens as potential vaccines in hepatocellular carcinoma

L. Buonaguro, B. Sangro, S. Hervás-Stubbs, 2022, Journal for ImmunoTherapy of Cancer.

IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination

S. Hervás-Stubbs, J. Lasarte, E. Guruceaga, 2016, Oncotarget.

The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

José L Carrascosa, Teresa Lozano, Pablo Sarobe, 2017, Oncoimmunology.

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma

B. Sangro, J. Lasarte, A. Lujambio, 2020, Cancers.

Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells

J. Prieto, J. Lasarte, J. Esteban, 2011, Hepatology.

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model

V. Trochon-Joseph, B. Sangro, J. Lasarte, 2018, Cancer Immunology, Immunotherapy.